CISAT, a CoPP-Induced lncRNA, Improves Cardiac Mesenchymal Progenitor Cell Survival and Myocardial Repair via SFPQ/NRF2/p38 Redox Regulation
Cells · 20.03.2026 · 15 (6) · 557
DOI: 10.3390/cells15060557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 20.03.2026. Verfasst von Xiuchun Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, RNA, Long Noncoding, p38 Mitogen-Activated Protein Kinases, NF-E2-Related Factor 2. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association, NIH HHS, NIH.
Abstract (Originalsprache)
Cellular therapy using human cardiac mesenchymal progenitor cells (hMPCs) for regenerative medicine is hindered by poor cell survival and senescence. Long non-coding RNAs (lncRNAs) are critical regulators of cellular processes, yet their role in cardiac aging remains underexplored. Here, lncRNA microarray profiling identified a novel lncRNA, XLOC_002543, upregulated in hMPCs preconditioned with cobalt protoporphyrin (CoPP), which was named CoPP-Induced and SFPQ-Associated RNA Transcript (CISAT) due to its interaction with splicing factor proline and glutamine rich (SFPQ), confirmed via RNA pull-down and immunoprecipitation. CISAT was the only highly expressed transcript among seven lnc-ANKMY1-5 variants in hMPCs, as shown by RT-PCR. Notably, CISAT expression decreased in aging/senescent hMPCs, correlating with elevated p16INK4A, a senescence marker. Overexpression of CISAT reduced p16INK4A levels; enhanced hMPC survival, proliferation, and migration; and increased antioxidant and anti-apoptotic protein expression, while CISAT knockdown reduced resistance to H2O2-induced oxidative stress. In vivo, intramyocardial transplantation of CISAT-overexpressed hMPCs in an immune-deficient murine myocardial infarction model reduced fibrosis, promoted angiogenesis, and preserved cardiac function. Mechanistically, CISAT interacts with SFPQ to regulate NRF2-mediated redox homeostasis and inhibits p38 MAPK phosphorylation, mitigating senescence and enhancing cell survival. These findings suggest that targeting CISAT to modulate redox signaling and p38 MAPK pathways in aging hMPCs could improve their therapeutic efficacy for myocardial repair in heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
- Department of Surgery, Division of Surgical Sciences, University of Virginia, Charlottesville, VA 22903, USA.
ORCID-Profile: Sofia Lopez
Förderung
- American Heart Association
- NIH HHS
- NIH
- AHA Transformational Project Awards
Zitieren
APA
Li, X., Wang, X. L., Lopez, S., Wang, J., & Cai, C. (2026). CISAT, a CoPP-Induced lncRNA, Improves Cardiac Mesenchymal Progenitor Cell Survival and Myocardial Repair via SFPQ/NRF2/p38 Redox Regulation. Cells, 15(6), 557. https://doi.org/10.3390/cells15060557
Vancouver
Li X, Wang XL, Lopez S, Wang J, Cai C. CISAT, a CoPP-Induced lncRNA, Improves Cardiac Mesenchymal Progenitor Cell Survival and Myocardial Repair via SFPQ/NRF2/p38 Redox Regulation. Cells. 2026;15(6):557. doi:10.3390/cells15060557
BibTeX
@article{Li2026,
author = {Li, Xiuchun and Wang, Xiao-Liang and Lopez, Sofia and Wang, Jill and Cai, Chuanxi},
title = {CISAT, a CoPP-Induced lncRNA, Improves Cardiac Mesenchymal Progenitor Cell Survival and Myocardial Repair via SFPQ/NRF2/p38 Redox Regulation},
journal = {Cells},
year = {2026},
volume = {15},
number = {6},
pages = {557},
doi = {10.3390/cells15060557}
}
EUVIMED